The now-bankrupt U.S. opioid manufacturer Purdue Pharma L.P. pleaded guilty on Tuesday to misleading the government about the sales of one of its drugs that played a role in the country’s opioid crisis. The confession ended the investigation that led to a multi-billion dollar settlement between the company and the Department of Justice (DOJ).